The Society for Vascular Medicine (SVM) is pleased to announce that two invited keynote speakers will address its 28th Annual Scientific Sessions, June 14-17, 2017, in New Orleans. Both addresses will be given on Thursday, June 15. Mark A. Creager, MD, FAHA, FACC, MSVM, will give the 2017 Founders' Lecture. C. Noel Bairey Merz, MD, FACC, FAHA, will present a keynote address on Sex-related Differences in Cardiovascular Disease to open a session called Vascular Disease in Women.
SVS Patient Safety Organization Announces New Vascular Medicine Registry
Posted Nov. 29, 2016
A new Vascular Medicine Registry will be launched in early 2017 by the Society for Vascular Surgery (SVS) and the Society for Vascular Medicine (SVM). The registry will be housed within the SVS Patient Safety Organization (SVS PSO), which was established to collect and analyze data to improve the quality of vascular care, and to do so in a neutral, de-identified environment. This will be the first data registry to study outcomes of medical management as compared to interventional and surgical treatments.
Aortic disease, including aortic aneurysm and aortic dissection, is an important cause of cardiovascular morbidity and death. There have been exciting developments in caring for patients with aortic aneurysm and dissection, including great advances in diagnosis and endovascular therapies. Despite this, there remains significant gaps in knowledge of the understanding of mechanisms of aortic pathology and opportunity to further improve patient care. With this in mind, Vascular Medicine, the official journal of the Society for Vascular Medicine, has dedicated its June 2016 issue to this important topic.
The Society for Vascular Medicine (SVM) is a part of a coalition of five leading nonprofit professional societies that has made recommendations for the treatment of peripheral artery disease (PAD) to the Centers for Medicare and Medicaid Services (CMS) Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) panel. The coalition’s recommendations are explained in an editorial that will appear in Vascular Medicine, the official journal of SVM. The editorial was made available on April 10 on the Vascular Medicine website.
The MEDCAC panel was convened to examine scientific evidence for lower-extremity PAD treatments that aim to improve health outcomes in Medicare beneficiaries and to address areas where evidence gaps exit related to lower-extremity PAD. The panel discussed care for patients with three levels of peripheral artery disease: asymptomatic, intermittent claudication, and critical limb ischemia.